David Spellman
Nessuna posizione attualmente
Patrimonio netto: 705 443 $ in data 29/02/2024
Profilo
David A.
Spellman is former Chief Financial Officer at Mersana Therapeutics, Inc., former Chief Financial & Business Officer at Intarcia Therapeutics, Inc., former Treasurer, Chief Financial & Accounting Officer of Akebia Therapeutics, Inc. and former VP-Commercial & International Finance at Vertex Pharmaceuticals, Inc.
He received an undergraduate degree from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
16/05/2023 | 446 483 ( 0.24% ) | 705 443 $ | 29/02/2024 |
Precedenti posizioni note di David Spellman
Società | Posizione | Fine |
---|---|---|
AKEBIA THERAPEUTICS, INC. | Director of Finance/CFO | 23/06/2023 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Director of Finance/CFO | 29/06/2020 |
MERSANA THERAPEUTICS, INC. | Director of Finance/CFO | 30/06/2019 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Formazione di David Spellman
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
MERSANA THERAPEUTICS, INC. | Health Technology |
AKEBIA THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |